ESMO 2022 Conference Coverage
ESMO 2022 Evaluation of the DNA Damage Response Network as a Predictor of Nivolumab Efficacy in HNSCC
By
ESMO 2022 Conference Coverage
FEATURING
Panagiota Oikonomopoulou
By
ESMO 2022 Conference Coverage
FEATURING
Panagiota Oikonomopoulou
Login to view comments.
Click here to Login
Head and Neck